Standard Biotools Inc (LAB)

R&D to Revenue

9.83%

Quarterly · Period ending:

LAB logo

LAB R&D to Revenue

Latest reported9.83%
LAB Quarterly R&D/Revenue (0.00% → 9.83%)
High-resolution chart · PNG

LAB r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Standard Biotools Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
9.8289%
10.0113%
32.717%
32.5082%
28.5911%
26.9014%
30.0805%
29.2557%
32.207%
35.09%
24.5104%
25.1114%
22.3523%
25.5942%
31.0018%
33.089%
67.1353%
33.4478%
22.3207%
32.3077%
30.4372%
32.7895%
25.0762%
20.3909%
32.42%
31.4987%
25.5179%
26.8909%
27.894%
27.8038%
24.6187%
25.6534%
27.9476%
28.7389%
25.7992%
31.0462%
31.2019%
33.3842%
34.9745%
41.6926%
35.4232%
35.8997%
31.7037%
32.9714%
35.2575%
37.3751%
34.9836%
42.8109%
41.1997%
29.7232%
26.493%
27.3637%
28.587%
28.8751%
27.2367%
31.8495%
30.7924%
39.0955%
30.7864%
31.0778%
32.3563%
37.0243%
28.1024%
40.893%
42.964%
47.4687%
40.2204%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.